Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » ArcherDx, Illumina Agree to Comarket Future IVDs

ArcherDx, Illumina Agree to Comarket Future IVDs

Jan 10, 2020
|
staff reporter

NEW YORK – ArcherDx said on Friday that it has signed a non-exclusive, multiyear partnership with Illumina intended to broaden access to next-generation sequencing oncology testing, including — upon regulatory approval — companion diagnostics for therapeutic selection, personalized monitoring, and new recurrence surveillance in vitro diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Mix of Human and Monkey

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

Fetal Tissue Policy Changes Expected

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Sequencing the Zoo

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

What's Popular?

In Business News

  1. Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

  2. People in the News: New Appointments at ACMG, InterVenn Biosciences, Castle Biosciences, More

  3. French Single-Cell Analysis Startup Minos Biosciences Raises €1.5M

  4. DiaSorin to Acquire Luminex for $1.8B

  5. Cancer Dx Firm C2i Genomics Raises $100M in Financing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.